Dextroamphetamine for Amphetamine Dependence: A Clinical Trial

We are studying whether daily prescribed dextroamphetamine can help reduce illicit amphetamine use in adults with amphetamine and opioid dependencies. The trial also looks at its effects on mental health, physical health, and overall quality of life.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Dexamfetamine Sulfate
Dexamfetamine sulfate is a stimulant that increases attention and reduces impulsivity and excessive sleepiness in people with ADHD or narcolepsy.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Helse Bergen HF
Avdeling for rusmedisin, Seksjon Forskning
Bergen, Norway
Finnmarkssykehuset HF
Department for Psychiatry and Addiction Medicine, Clinic Alta
Hammerfest, Norway
Vestfold Hospital Trust
Division of Mental Health and Addiction, Vestfold Hospital Trust
Holmestrand, Norway

Sponsor: Helse Bergen HF
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.